• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Sex differences in disease course: analysis of the Swiss HIV cohort study].

作者信息

Schmid M, Twisselmann W, Jacquat B J, Ledergerber B, Battegay M, Egger M

机构信息

Koordinationsstelle Gesundheit von Frauen, Zürich, Institut für Sozial- und Präventivmedizin, Universität Zürich.

出版信息

Schweiz Med Wochenschr. 1996 Dec 28;126(51-52):2234-6.

PMID:9011933
Abstract

The Swiss HIV Cohort Study (SHCS) is a prospective multicentre study of HIV-infected adults. Participants have been followed up at six-monthly intervals since 1988. The purpose of the present study was to examine sex differences in developing AIDS-defining events and in survival among participants of the SHCS (1042 women, 1507 men). A statistically significant higher risk of Pneumocystis carinii pneumonia (PCP) was evident among women. This difference was particularly pronounced in 1989 (hazard ratio 2.11, p = 0.01). Other opportunistic events and survival showed no statistically significant sex differences. The results are compatible with slower introduction of PCP prophylaxis among women. A reason for this may be that women were less likely to be enrolled in clinical trials than men. This hypothesis will be examined in a further study.

摘要

相似文献

1
[Sex differences in disease course: analysis of the Swiss HIV cohort study].
Schweiz Med Wochenschr. 1996 Dec 28;126(51-52):2234-6.
2
Early participation in an HIV cohort study slows disease progression and improves survival. The Swiss HIV Cohort Study.早期参与一项HIV队列研究可减缓疾病进展并提高生存率。瑞士HIV队列研究。
J Intern Med. 1998 Dec;244(6):479-87.
3
Clinical epidemiology and research on HIV infection in Switzerland: the Swiss HIV Cohort Study 1988-2000.瑞士HIV感染的临床流行病学与研究:瑞士HIV队列研究(1988 - 2000年)
Schweiz Med Wochenschr. 2000 Oct 14;130(41):1493-500.
4
Pneumocystis carinii pneumonia in the Federal Republic of Germany in the era of changing antiretroviral therapy - IDKF 13 -. German AIDS Study Group (GASG/IdKF).德国艾滋病研究组(GASG/IdKF):抗逆转录病毒治疗变革时代的德国卡氏肺孢子虫肺炎——IDKF 13 -
Eur J Med Res. 1999 Apr 27;4(4):131-4.
5
[Impact of zidovudine treatment and the pneumocystis carinii prophylaxis in natural history of patients with HIV infection].[齐多夫定治疗及卡氏肺孢子虫预防对HIV感染患者自然病程的影响]
An Med Interna. 1998 Mar;15(3):132-7.
6
[Incidence of bacterial pneumonia in HIV-positive patients treated with preventive co-trimoxazole or pentamidine].[接受预防性复方新诺明或喷他脒治疗的HIV阳性患者细菌性肺炎的发病率]
Pneumologie. 1998 Nov;52(11):614-21.
7
The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.已停止机会性感染预防的免疫重建的HIV感染儿童中严重细菌感染的发生率。
Pediatrics. 2005 Apr;115(4):e488-94. doi: 10.1542/peds.2004-1847. Epub 2005 Mar 16.
8
Low incidence of community-acquired pneumonia among human immunodeficiency virus-infected patients after interruption of Pneumocystis carinii pneumonia prophylaxis.卡氏肺孢子虫肺炎预防措施中断后,人类免疫缺陷病毒感染患者社区获得性肺炎的发生率较低。
Clin Infect Dis. 2003 Apr 1;36(7):917-21. doi: 10.1086/368190. Epub 2003 Mar 18.
9
[Cause of death and autopsy findings in patients of the Swiss HIV Cohort Study (SHCS)].[瑞士HIV队列研究(SHCS)患者的死因及尸检结果]
Schweiz Med Wochenschr. 2000 Nov 11;130(45):1726-33.
10
Twice-weekly pyrimethamine-sulfadoxine effectively prevents Pneumocystis carinii pneumonia relapse and toxoplasmic encephalitis in patients with AIDS.每周两次服用乙胺嘧啶-磺胺多辛可有效预防艾滋病患者卡氏肺孢子虫肺炎复发和弓形虫性脑炎。
J Infect. 2001 Jan;42(1):8-15. doi: 10.1053/jinf.2000.0772.